About this trial
There are Billroth-I, Billroth-II, Billroth-II with Braun, and Roux-en-Y reconstruction after distal gastrectomy.
Hypothesis: Billroth-II modified method is non-inferior to Roux-en-Y method in terms of reducing reflux esophagitis after distal gastrectomy for gastric cancer patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients confirmed with gastric cancer
Indicated for radical distal gastrectomy (cT1 to cT4a, any N, M0; according to AJCC/UICC 8th TNM staging for gastric cancer)
Age from 18- to 80-year-old
Agreed to participate in study with written inform consent
Disqualifiers
Pregnant patients
An American Society of Anesthesiology (ASA) score of higher than 4
Concurrent cancer or history of previous other cancers
Previous gastrectomy
Trial design
Parallel
Treatments tested in this trial
Distal gastrectomy
Procedure/SurgeryReconstruction after Distal Gastrectomy
Treatment groups
Trial outcomes
Primary outcomes
Reflux esophagistis
Findings of reflux esophagitis according to Los Angeles classification via endoscopy
Secondary outcomes
Early complications
Rate of any complications happened intraoperative and 30-days post-operative
Operative time
Time from first incision to finishing abdomen closure, measured by surgical nurse
Time for making anastomosis
Time from jejunal stapler opening (for B-II) or from jejunal separating (for R-II) to finishing enhancing suture (including duodenal stump enhancement)
Blood loss
Weighing of sucked blood and gauze, minus weighing of dry gauze
Sponsors and contacts
Click on the lead sponsor to view all of their trials.